Hypoxia is a common feature of solid tumors and predicts poor clinical outcome. Hypoxic tumor cells are resistant to radiation therapy and exhibit more aggressive phenotype. It has been suggested that hypoxic tumor cells possess undifferentiated characteristics and highly aggresive properties. Other evidence suggests that undifferentiated cells may potentially be more resistant to radiation than are differentiated cells, and recently, the hypoxia-inducible factor-1 (HIF-1) has been implicated in the regulation of radiation sensitivity of solid tumors. However, it remains unclear how hypoxia regulates tumor cell differentiation. We have begun to investigate the role of hypoxia in regulating cell differentiation using several model systems. Our data have shown that hypoxia inhibits cell differentiation and can arrest precursor/stem cells in their undifferentiated state. In our preliminary studies, we have aslo found that hypoxia inhibits differentiation of cancer cells and protects their clonogenic potential. These lines of evidence prompt us to hypothesize that hypoxia promotes tumor malignancy and resistance to radiation therapy, in part, by maintaining tumorigenic cells in their undifferentiated state. In this proposal, we will use neuroblastoma as a model to test this hypothesis by focusing on the following four working hypotheses. 1. Hypoxia inhibits differentiation of neuroblastoma cells in vitro. 2. Hypoxia maintains the poorly differentiated neuroblastoma cell population in hypoxic tumors. 3. The hypoxia inducible factor (HIF) regulates undifferentiated phenotype of neuroblastoma cells. 4. Hypoxia induces dedifferentiation of neuroblastoma. This proposal is innovative as it addresses the regulation of stem/precursor phenotype by tumor microenvironment, an important mechanism for tumor progression that has not yet been well understood. Our proposal will potentially provide new insight into how hypoxia increases tumor resistance to therapy and promotes malignant progression. Such insight could lead to new strategies to target the regulation of tumor cell differentiation as a form of cancer therapy.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA125021-04
Application #
7841852
Study Section
Radiation Therapeutics and Biology Study Section (RTB)
Program Officer
Bernhard, Eric J
Project Start
2007-07-01
Project End
2012-03-31
Budget Start
2010-04-01
Budget End
2011-03-31
Support Year
4
Fiscal Year
2010
Total Cost
$314,450
Indirect Cost
Name
Yale University
Department
Radiation-Diagnostic/Oncology
Type
Schools of Medicine
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
06520
McCarthy, Thomas L; Yun, Zhong; Madri, Joseph A et al. (2014) Stratified control of IGF-I expression by hypoxia and stress hormones in osteoblasts. Gene 539:141-51
Yun, Zhong; Lin, Qun (2014) Hypoxia and regulation of cancer cell stemness. Adv Exp Med Biol 772:41-53
Begum, Asma; Lin, Qun; Yu, Chenye et al. (2014) Interaction of delta-like 1 homolog (Drosophila) with prohibitins and its impact on tumor cell clonogenicity. Mol Cancer Res 12:155-64
Begum, Asma; Kim, Yuri; Lin, Qun et al. (2012) DLK1, delta-like 1 homolog (Drosophila), regulates tumor cell differentiation in vivo. Cancer Lett 318:26-33
Lin, Qun; Cong, Xiangyu; Yun, Zhong (2011) Differential hypoxic regulation of hypoxia-inducible factors 1alpha and 2alpha. Mol Cancer Res 9:757-65
Lin, Qun; Yun, Zhong (2010) Impact of the hypoxic tumor microenvironment on the regulation of cancer stem cell characteristics. Cancer Biol Ther 9:949-56
Kim, Yuri; Lin, Qun; Zelterman, Daniel et al. (2009) Hypoxia-regulated delta-like 1 homologue enhances cancer cell stemness and tumorigenicity. Cancer Res 69:9271-80
Kim, Yuri; Lin, Qun; Glazer, Peter M et al. (2009) Hypoxic tumor microenvironment and cancer cell differentiation. Curr Mol Med 9:425-34
Lin, Qun; Kim, Yuri; Alarcon, Rodolfo M et al. (2008) Oxygen and Cell Fate Decisions. Gene Regul Syst Bio 2:43-51